404 related articles for article (PubMed ID: 19178144)
21. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H
J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787
[TBL] [Abstract][Full Text] [Related]
24. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
[TBL] [Abstract][Full Text] [Related]
25. In vivo real-time bioimaging of hyaluronic acid derivatives using quantum dots.
Kim J; Kim KS; Jiang G; Kang H; Kim S; Kim BS; Park MH; Hahn SK
Biopolymers; 2008 Dec; 89(12):1144-53. PubMed ID: 18690665
[TBL] [Abstract][Full Text] [Related]
26. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
27. Reducible hyaluronic acid-siRNA conjugate for target specific gene silencing.
Park K; Yang JA; Lee MY; Lee H; Hahn SK
Bioconjug Chem; 2013 Jul; 24(7):1201-9. PubMed ID: 23731084
[TBL] [Abstract][Full Text] [Related]
28. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.
Alshamsan A; Haddadi A; Incani V; Samuel J; Lavasanifar A; Uludağ H
Mol Pharm; 2009; 6(1):121-33. PubMed ID: 19053537
[TBL] [Abstract][Full Text] [Related]
29. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
[TBL] [Abstract][Full Text] [Related]
30. A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing.
Tsai LR; Chen MH; Chien CT; Chen MK; Lin FS; Lin KM; Hwu YK; Yang CS; Lin SY
Biomaterials; 2011 May; 32(14):3647-53. PubMed ID: 21324524
[TBL] [Abstract][Full Text] [Related]
31. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
32. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
33. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
34. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
35. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.
Lee SH; Kim SH; Park TG
Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451
[TBL] [Abstract][Full Text] [Related]
36. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.
Han SE; Kang H; Shim GY; Kim SJ; Choi HG; Kim J; Hahn SK; Oh YK
J Drug Target; 2009 Feb; 17(2):123-32. PubMed ID: 19012052
[TBL] [Abstract][Full Text] [Related]
37. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine.
Shim MS; Kwon YJ
Biomacromolecules; 2008 Feb; 9(2):444-55. PubMed ID: 18186606
[TBL] [Abstract][Full Text] [Related]
38. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Koldehoff M; Beelen DW; Elmaagacli AH
J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
[TBL] [Abstract][Full Text] [Related]
39. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
[TBL] [Abstract][Full Text] [Related]
40. Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier.
Kang JH; Tachibana Y; Kamata W; Mahara A; Harada-Shiba M; Yamaoka T
Bioorg Med Chem; 2010 Jun; 18(11):3946-50. PubMed ID: 20472444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
